HOME Research Insight Key Players in the Antinuclear Antibody Test Testing Market Have a Major Focus on Acquisitions, New Product Launches, Agreements, and Expansions



Key Players in the Antinuclear Antibody Test Testing Market Have a Major Focus on Acquisitions, New Product Launches, Agreements, and Expansions


The ANA testing market is consolidated in nature due to the presence of a few large players operating in this market. The prominent players in the ANA testing market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S. ), and Zeus Scientific, Inc. (U.S.).

Thermo Fisher Scientific was the leading player in the global ANA testing market in 2015. The company has a strong presence in North America, Europe, Asia, and Latin America. It focuses on expanding its presence in the ANA testing market by strategically investing in research and development activities, which enables it to launch new products in the market. For instance, in July 2015, Thermo Fisher Scientific introduced the Phadia 2500E Laboratory System and EliA PR3s, MPOs, and GBM Assays. Such launches have strengthened the company’s portfolio in the ANA testing market.

Alere Inc. (U.S.) is the second-largest player in the global ANA testing market, with a share of 15.6% in 2014. Alere operates in more than 100 countries across the globe, including the U.S., Austria, Denmark, China, Brazil, Indonesia, South Africa, and Japan. The company focuses on new product launches to strengthen its portfolio in the ANA testing market.

Bio-Rad Laboratories, Inc. (U.S.) is the third-largest player in the global ANA testing market, with a share of 9.5% in 2014. Bio-Rad caters to the life science research and clinical diagnostics market by developing and supplying novel products and services. The company’s product portfolio comprises analysis kits, reagents, and systems for antinuclear antibody testing. It focuses on new product launches and acquisitions as its key growth strategies.

Based on the analysis of strategic developments undertaken by market players between 2012 and 2016, the key strategies followed by most companies in the ANA testing market are new product launches, expansions, acquisitions, and agreements. Some of the leading players that adopted this strategy include Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Trinity Biotech plc (Ireland), EUROIMMUN AG (Germany), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).

Related Reports:

Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Forecast to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports